John D. Quisel, SVP, Corporate Development, GC & Secretary at ACCELERON PHARMA INC (XLRN), sold 5,113 shares at $38.29 ($196K) on 2017-09-12, disclosed to the SEC on 2017-09-14.
Seasonal sale ($196k) by SVP, Corporate Development, GC & Secretary — this insider has traded XLRN in September in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.29 | 4,505 | $172K | 87.8% |
| 2 | $39.37 | 600 | $24K | 12.0% |
| 3 | $38.03 | 8 | $304 | 0.2% |
| Total | $38.42 avg | 5,113 | $196K | 100% |
| Filing → |
| IRON | SELL | 2026-06-23 | $2.4M | — | Filing → |
| IRON | SELL | 2026-02-17 | $834K | — | Filing → |
| IRON | SELL | 2025-12-15 | $7.4M | — | Filing → |